ICSMA-20-170-02

Vulnerability from csaf_cisa - Published: 2020-06-18 00:00 - Updated: 2020-07-14 00:00
Summary
Baxter PrismaFlex and PrisMax (Update B)

Notes

CISA Disclaimer
This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov
Legal Notice
All information products included in https://us-cert.cisa.gov/ics are provided "as is" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.
Risk evaluation
Successful exploitation of these vulnerabilities may allow an attacker with network access to view and alter sensitive data.
Critical infrastructure sectors
Healthcare and Public Health
Countries/areas deployed
Worldwide
Company headquarters location
United States
Recommended Practices
CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities. Specifically, users should:
Recommended Practices
CISA also provides a section for control systems security recommended practices on the ICS webpage onus-cert.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Recommended Practices
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.gov in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies. Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.
Exploitability
No known public exploits specifically target these vulnerabilities.
To clipboard 

{
  "document": {
    "acknowledgments": [
      {
        "names": [
          "Baxter"
        ],
        "summary": "reporting these vulnerabilities to CISA"
      }
    ],
    "category": "csaf_security_advisory",
    "csaf_version": "2.0",
    "distribution": {
      "text": "Disclosure is not limited",
      "tlp": {
        "label": "WHITE",
        "url": "https://us-cert.cisa.gov/tlp/"
      }
    },
    "lang": "en-US",
    "notes": [
      {
        "category": "general",
        "text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
        "title": "CISA Disclaimer"
      },
      {
        "category": "legal_disclaimer",
        "text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
        "title": "Legal Notice"
      },
      {
        "category": "summary",
        "text": "Successful exploitation of these vulnerabilities may allow an attacker with network access to view and alter sensitive data.",
        "title": "Risk evaluation"
      },
      {
        "category": "other",
        "text": "Healthcare and Public Health",
        "title": "Critical infrastructure sectors"
      },
      {
        "category": "other",
        "text": "Worldwide",
        "title": "Countries/areas deployed"
      },
      {
        "category": "other",
        "text": "United States",
        "title": "Company headquarters location"
      },
      {
        "category": "general",
        "text": "CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities. Specifically, users should:",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA also provides a section for control systems security recommended practices on the ICS webpage onus-cert.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.gov in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.\nOrganizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.",
        "title": "Recommended Practices"
      },
      {
        "category": "other",
        "text": "No known public exploits specifically target these vulnerabilities.",
        "title": "Exploitability"
      }
    ],
    "publisher": {
      "category": "coordinator",
      "contact_details": "Email: CISAservicedesk@cisa.dhs.gov;\n Toll Free: 1-888-282-0870",
      "name": "CISA",
      "namespace": "https://www.cisa.gov/"
    },
    "references": [
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-20-170-02 JSON",
        "url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2020/icsma-20-170-02.json"
      },
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-20-170-02 Web Version",
        "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-20-170-02"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.fda.gov/medical-devices/digital-health/cybersecurity"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.us-cert.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.us-cert.gov/ics/tips/ICS-TIP-12-146-01B"
      }
    ],
    "title": "Baxter PrismaFlex and PrisMax (Update B)",
    "tracking": {
      "current_release_date": "2020-07-14T00:00:00.000000Z",
      "generator": {
        "engine": {
          "name": "CISA CSAF Generator",
          "version": "1.0.0"
        }
      },
      "id": "ICSMA-20-170-02",
      "initial_release_date": "2020-06-18T00:00:00.000000Z",
      "revision_history": [
        {
          "date": "2020-06-18T00:00:00.000000Z",
          "legacy_version": "Initial",
          "number": "1",
          "summary": "ICSMA-20-170-02 Baxter PrismaFlex and PrisMax "
        },
        {
          "date": "2020-06-23T00:00:00.000000Z",
          "legacy_version": "A",
          "number": "2",
          "summary": "ICSMA-20-170-02 Baxter PrismaFlex (Update A)"
        },
        {
          "date": "2020-07-14T00:00:00.000000Z",
          "legacy_version": "B",
          "number": "3",
          "summary": "ICSMA-20-170-02 Baxter PrismaFlex and PrisMax (Update B)"
        }
      ],
      "status": "final",
      "version": "3"
    }
  },
  "product_tree": {
    "branches": [
      {
        "branches": [
          {
            "branches": [
              {
                "category": "product_version_range",
                "name": "\u003c 3.x",
                "product": {
                  "name": "PrisMax: all versions prior to 3.x",
                  "product_id": "CSAFPID-0001"
                }
              }
            ],
            "category": "product_name",
            "name": "PrisMax"
          },
          {
            "branches": [
              {
                "category": "product_version",
                "name": "vers:all/*",
                "product": {
                  "name": "PrismaFlex: all versions",
                  "product_id": "CSAFPID-0002"
                }
              }
            ],
            "category": "product_name",
            "name": "PrismaFlex"
          }
        ],
        "category": "vendor",
        "name": "Baxter"
      }
    ]
  },
  "vulnerabilities": [
    {
      "cve": "CVE-2020-12036",
      "cwe": {
        "id": "CWE-319",
        "name": "Cleartext Transmission of Sensitive Information"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.CVE-2020-12036 has been assigned to this vulnerability. A CVSS v3 base score of 6.5 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-12036"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Prismaflex versions SW 8.2x include the option to set a device specific service password. Note: Prismaflex Versions SW 8.2x are not available in all regions, including the United States.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "For PrisMax, Baxter recommends users upgrade to PrisMaxv3 with DCM (Digital Communication Module), which supports mutually authenticated TLS tunnel to a PDMS or EMR system capable of implementing the latest TLS 1.2.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "Additionally, Baxter recommends users of affected devices implement the following best practices:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "Baxter also recommends that if a PDMS or EMR system is used with the affected devices, users should verify compatibility between the two systems. Users should also identify, analyze, evaluate, and control all risks associated with integration of medical devices in an enterprise network. Subsequent changes to the enterprise network could introduce new risks and require new analysis. The use of a PDMS or EMR system not compatible with the PrismaFlex and PrisMax systems can result in the presentation of erroneous data.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "For additional information please see the Baxter Product Security Bulletins for PrismaFlex and PrisMax.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.baxter.com/product-security#additionalresources"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 6.5,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2020-12035",
      "cwe": {
        "id": "CWE-287",
        "name": "Improper Authentication"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The affected devices do not require authentication when configured to send treatment data to a PDMS or an EMR system. This could allow an attacker to modify treatment status information.CVE-2020-12035 has been assigned to this vulnerability. A CVSS v3 base score of 7.6 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:L).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-12035"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:L"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Prismaflex versions SW 8.2x include the option to set a device specific service password. Note: Prismaflex Versions SW 8.2x are not available in all regions, including the United States.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "For PrisMax, Baxter recommends users upgrade to PrisMaxv3 with DCM (Digital Communication Module), which supports mutually authenticated TLS tunnel to a PDMS or EMR system capable of implementing the latest TLS 1.2.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "Additionally, Baxter recommends users of affected devices implement the following best practices:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "Baxter also recommends that if a PDMS or EMR system is used with the affected devices, users should verify compatibility between the two systems. Users should also identify, analyze, evaluate, and control all risks associated with integration of medical devices in an enterprise network. Subsequent changes to the enterprise network could introduce new risks and require new analysis. The use of a PDMS or EMR system not compatible with the PrismaFlex and PrisMax systems can result in the presentation of erroneous data.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "For additional information please see the Baxter Product Security Bulletins for PrismaFlex and PrisMax.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.baxter.com/product-security#additionalresources"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 7.6,
            "baseSeverity": "HIGH",
            "vectorString": "CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:L",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2020-12037",
      "cwe": {
        "id": "CWE-259",
        "name": "Use of Hard-coded Password"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The PrismaFlex device contains a hard-coded service password that provides access to biomedical information, device settings, calibration settings, and network configuration. This could allow an attacker to modify device settings and calibration.CVE-2020-12037 has been assigned to this vulnerability. A CVSS v3 base score of 5.4 has been calculated; the CVSS vector string is (AV:P/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:L).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-12037"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:L"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Prismaflex versions SW 8.2x include the option to set a device specific service password. Note: Prismaflex Versions SW 8.2x are not available in all regions, including the United States.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "For PrisMax, Baxter recommends users upgrade to PrisMaxv3 with DCM (Digital Communication Module), which supports mutually authenticated TLS tunnel to a PDMS or EMR system capable of implementing the latest TLS 1.2.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "Additionally, Baxter recommends users of affected devices implement the following best practices:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "Baxter also recommends that if a PDMS or EMR system is used with the affected devices, users should verify compatibility between the two systems. Users should also identify, analyze, evaluate, and control all risks associated with integration of medical devices in an enterprise network. Subsequent changes to the enterprise network could introduce new risks and require new analysis. The use of a PDMS or EMR system not compatible with the PrismaFlex and PrisMax systems can result in the presentation of erroneous data.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "For additional information please see the Baxter Product Security Bulletins for PrismaFlex and PrisMax.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.baxter.com/product-security#additionalresources"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 5.4,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:P/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:L",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        }
      ]
    }
  ]
}


Log in or create an account to share your comment.




Tags
Taxonomy of the tags.




Sightings

Author Source Type Date

Nomenclature

  • Seen: The vulnerability was mentioned, discussed, or observed by the user.
  • Confirmed: The vulnerability has been validated from an analyst's perspective.
  • Published Proof of Concept: A public proof of concept is available for this vulnerability.
  • Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
  • Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
  • Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
  • Not confirmed: The user expressed doubt about the validity of the vulnerability.
  • Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.



Detection rules are retrieved from Rulezet.